Ebitda Changement Date
AbbVie USD 6.91B 3.22B 2026-06
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
AstraZeneca USD 7.46B 2.3B 2026-09
Curis USD -12.3M 231K 2023-09
Cytokinetics USD -160.3M 9.02M 2026-06
Gilead Sciences USD -9.31B 12.82B 2026-06
Incyte USD 778.57M 410.6M 2026-06
Laboratory Of America USD 674.3M 93.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Pfizer USD 6.36B 350M 2026-09
Roche Holding CHF 13.43B 744M 2026-06
TG Therapeutics USD 26.9M 1.21M 2026-06